Community/Retail

Value-added pharmacy services come in all shapes and sizes.

Pharmacy giants Walgreens and CVS are taking extensive steps to ensure patient access to medications during the novel coronavirus (COVID-19) pandemic, including waiving drug delivery fees and expanding telehealth options.

The approval allows Florida to waive certain requirements in Medicare, Medicaid, and CHIP.

Researchers and senior physicians support a French official’s warning that individuals showing symptoms of the novel coronavirus should use paracetamol rather than ibuprofen.

Some pharmacists and technicians are reporting that they don’t have enough personal protective equipment behind the counter.

Recently, many providers have become worried about the potential of certain medications to worsen transmission and outcomes in the setting of the global COVID-19 pandemic.

Patients who received an opioid after tooth extraction reported higher levels of pain than patients who received a non-opioid.

Conferences such as the American Pharmacists Association (APhA) 2020 Annual Meeting and Expo are now implementing virtual versions of their programs.

Although vaccine development is underway, the process can take at least a year before reaching in the mass-production stage.

West Virginia legislature passes a bill that will affect reimbursement for services that fall within a pharmacist’s purview and are ordinarily provided by other health care providers.

More than 10% of COVID-19 patients were infected by an asymptomatic person, according to new research.

The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.

A 72-week interim analysis of observational data from the ongoing SEARCH study was used to examine optimal strategies for PrEP engagement and uptake after population-level HIV testing and universal PrEP access.

A clinical program evaluating sarilumab (Kevzara, Sanofi and Regeneron) has started in patients hospitalized with a severe form of the novel coronavirus (COVID-19), according to the company.

The authorizations have been given to Hologic for its Panther Fusion SARS-CoV-2 Assay and to Laboratory Corporation of America for its COVID-19 reverse transcription polymerase chain reaction test.

A new executive order from Kentucky Gov. Andy Beshear has expanded prescribing rights to pharmacists in light of the novel coronavirus.

The spray is the first nasal spray treatment for seizure cluster rescue.

The first clinical trial evaluating an investigational vaccine designed to protect against the novel coronavirus (COVID-19) has begun.

Protecting pharmacy staff is vital to ensuring continued care during the COVID-19 outbreak.

French health officials have warned that widely used OTC anti-inflammatory drugs may worsen the novel coronavirus known as COVID-19, whereas others say more evidence is needed.

How can this patient better tolerate polyethylene glycol (PEG)-electrolyte lavage solution?

In response to growing concern surrounding the novel coronavirus, Cedarville University School of Pharmacy and Cedar Care Village Pharmacy presented an online town hall meeting with an infectious disease expert.

As one of the most visible members of the health care team, pharmacists are uniquely positioned to assist and support patients in tobacco cessation.

Pharmacies across the country also taking necessary steps to help facilitate COVID-19 testing and to keep patients safe.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.

As the novel coronavirus (COVID-19) pandemic continues to spread, the World Health Organization (WHO) is urging the public to follow proper safety procedures and support each other, according to the latest press conference.

President Donald Trump announced the “national emergency” designation in a news conference Friday.

The FDA has approved olopatadine hydrochloride ophthalmic 0.1% and 0.2% solution for sale as an OTC medication in the United States.

In its first action, the FDA has decided to not object to the New York State Department of Health’s (NYSDOH) action authorizing certain laboratories in New York to start patient testing for COVID-19.

A bipartisan coalition in Congress has introduced new legislation designed to ensure Medicare patients have access to Part B home infusion medications.